rather than bashing for pennies spend you internet time pursuing an education at one of the free online learning sites. For example, you need to learn math so you can correctly interpret the changes in scripts which are INCREASING.
To run to completion does not mean no good news at interim. Running longer gives more data for subgroup analysis. Of course that is the plan. To imply this is news or bad news is intentionally misleading. But you know that.
Salmon would cost you more than most people pay for co-pays.
And since you are so worried about studies, where is the study that shows a pound a day of salmon has the same effect as Vasepa?
You obviously didn't read the clr letter or fda statements and testimony if you think AMRN could proactively share info with doctors.
Try reading the transcript so you understand the implications. Oh, wait, you do understand that is why the all out bashing brigade.
That's why FDA fought in court. Sure. This is a very big deal and will take a. Few weeks for folks to grasp the impacts - and not just in scripts but in several other ways. Watch and learn.
solid report, good tone. talks with multiple countries/partners, strong confidence in products - inflammation role etc. Very positive on NCE and patent protection. Planning advertising campaign for post A1 decision. Time will tell.
Hey wes_newhouse5 suggest your start reading the thousands of pages of medical evidence regarding the anti-inflammatory and other benefits of correct dosages of EPA before you repeat your misrepresentation of Jellis for the umpteenth time.
" Why is everyone leaving AMRN?" They are not leaving AMRN, just leaving the board because of ignoramouses who parrot half truths and lies incessantly.
You have repeatedly been directed to resourced that rebut your accusations. Seems you can't read or can't comprehend. Oh, wait, maybe you think you can scare someone into selling.
No other Omega 3 study or EPA study has used mineral oil placebo. Why?
Mineral oil is used frequently and was approved by FDA. This bogus issue has long been dismissed as irrrelevant for a long term study. But you kow that and intentionally ignored it.
LDL-C increased a median 9% in the placebo group, despite statin therapy.
FDA has always expressed concern of the use of mineral oil used as a placebo in the "Anchor" study.
Not "always" just once as a hypothesis at ADCOM just like they raised safety as an issue for one of the safest drugs ever.
LDL-C increased a median 9% in the placebo group
How long was the Anchor study? just sayin.